Roivant Sciences Ltd
ROIVHealthcare·Biotechnology·United Kingdom·Large·NASD·Nov 13 • 8:06 AM ET
40.00+0.01 (0.03%)
2026-11-13 14:06 CET
Market cap
$28.98B
Revenue, TTM
41.08 USD m
Net income, TTM
-360.12 USD m
Free cash flow, TTM
-33.34 USD m
EPS diluted, TTM
-0.56
Price
ROIV against its 20, 50 and 200-day averagesPatternshover a marker to name it
5.9% under the 52-week high of 42.50 on 8 Sep 2026. 52-week low 19.96 on 2 Dec 2025. Last 15 sessions, 18.8% high to low
Volume 0.01× normal · the line is the 50-bar volume average
Setup. RS line 98
CANSLIM 4 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%)
VCP 6 of 6
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%
Profile
ROIV52-week range, 89% of the way up
19.9642.50
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
| Index | RUI |
|---|---|
| Employees | 721 |
| IPO | Dec 08, 2020 |
| Beta | 1.20 |
| ATR, 14d | 1.56 |
| Rel volume | 0.01 |
| Short float | 8.65% |
| Insider own | 27.42% |
| Inst own | 77.16% |
Snapshot
6 groupsValuation
| Index | RUI |
|---|---|
| Market Cap | $28.98B |
| Enterprise Value | 25.46B |
| Income | -360.12M |
| Sales | 41.08M |
| Book / share | 5.56 |
| Cash / share | 5.81 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 721 |
| IPO | Dec 08, 2020 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 705.51 |
| Price / book | 7.20 |
| Price / cash | 6.89 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 619.69 |
| Quick Ratio | 15.56 |
| Current Ratio | 15.56 |
| Debt / equity | 0.03 |
| Long-term debt / equity | 0.02 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.56 |
|---|---|
| Earnings next year | -1.14 |
| Earnings next quarter | -0.30 |
| Earnings this year | -118.03% |
| Earnings next year | 3.07% |
| Earnings growth, 5 years | 0.09% |
| Past earnings growth | 32.67% 34.68% |
| Past sales growth | -48.73% -19.07% |
| Earnings vs last year | 9.46% |
| Sales vs last year | 102.09% |
| Earnings vs last quarter | -72.11% |
| Sales vs last quarter | 2135.58% |
| Earnings | Nov 09 BMO |
| Surprise | 26.35% 709.97% |
Ownership
| Insiders own | 27.42% |
|---|---|
| Insider trades | -3.72% |
| Institutions own | 77.16% |
| Institution trades | 2.79% |
| Return on assets | -7.17% |
| Return on equity | -8.59% |
| Return on capital | -8.76% |
| Gross Margin | 82.51% |
| Operating margin | -3233.98% |
| Profit Margin | -876.58% |
| 20-day average | 6.12% |
| 50-day average | 7.20% |
| 200-day average | 23.79% |
Technical
| Shares out | 723.69M |
|---|---|
| Shares floating | 525.91M |
| Short / float | 8.65% |
| Short ratio | 5.66 |
| Short interest | 45.51M |
| 52-week high | 42.50 -5.9% |
| 52-week low | 19.96 +100.4% |
| Volatility | 4.69% 4.06% |
| Average range | 1.56 |
| Strength index | 59.08 |
| Market sensitivity | 1.20 |
| Relative volume | 0.01 |
| Avg Volume | 8.05M |
| Volume | 5,093 |
Performance
| Perf Week | 2.88% |
|---|---|
| Perf Month | 17.51% |
| Perf Quarter | 10.38% |
| Perf Half Y | 36.57% |
| Perf YTD | 84.33% |
| Perf Year | 94.55% |
| Perf 3Y | 341.99% |
| Perf 5Y | 376.19% |
| Perf 10Y | - |
| Recommendation | 1.40 |
| Target Price | 50.64 |
| Prev Close | 39.99 |
| Price | 40.00 |
| Change % | 0.03% |
Analyst ratings
latest 10 of 19| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 12, 2026 | Downgrade | Wolfe Research | Outperform → Peer Perform | ||
| Sep 17, 2026 | Initiated | Stifel | Buy | $51 | +27.5% |
| Mar 20, 2026 | Initiated | Bernstein | Outperform | $35 | -12.5% |
| Sep 02, 2025 | Initiated | Citigroup | Buy | $16 | -60.0% |
| Jul 10, 2025 | Resumed | Goldman | Buy | $19 | -52.5% |
| Feb 15, 2024 | Initiated | Wolfe Research | Outperform | $17 | -57.5% |
| Jan 05, 2024 | Initiated | Piper Sandler | Overweight | $20 | -50.0% |
| Dec 12, 2023 | Initiated | Deutsche Bank | Buy | $14 | -65.0% |
| Oct 17, 2023 | Initiated | Guggenheim | Buy | $17 | -57.5% |
| Jun 08, 2023 | Initiated | BofA Securities | Neutral | $10.50 | -73.7% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ARGX | Argen X SE ADR | 61.91B |
| INCY | Incyte Corp | 24.81B |
| BBIO | BridgeBio Pharma Inc | 15.35B |
| ALNY | Alnylam Pharmaceuticals Inc | 21.25B |
| ABVX | Abivax ADR | 7.89B |
| INSM | Insmed Inc | 25.79B |
| REGN | Regeneron Pharmaceuticals Inc | 98.85B |
| MRNA | Moderna Inc | 92.84B |
| VRTX | Vertex Pharmaceuticals Inc | 137.80B |
| IONS | Ionis Pharmaceuticals Inc | 4.56B |
Insider trading
latest 14 of 100| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Pulik Richard | CFO | Nov 11 '26 | Option Exercise | 3.85 | 127,365 | 490,355 | 397,046 | Nov 12 07:01 PM |
| Pulik Richard | CFO | Nov 10 '26 | Option Exercise | 3.85 | 125,000 | 481,250 | 394,681 | Nov 12 07:01 PM |
| Pulik Richard | CFO | Nov 11 '26 | Sale | 41.85 | 175,000 | 7,323,272 | 222,046 | Nov 12 07:01 PM |
| Pulik Richard | CFO | Nov 10 '26 | Sale | 41.20 | 125,000 | 5,150,000 | 269,681 | Nov 12 07:01 PM |
| Venker Eric | President & Immunovant CEO | Nov 10 '26 | Sale | 40.53 | 187,943 | 7,617,074 | 811,211 | Nov 12 07:00 PM |
| RICHARD PULIK | Officer | Nov 11 '26 | Proposed Sale | 41.85 | 175,000 | 7,323,568 | Nov 12 08:49 AM | |
| Venker Eric | Officer | Nov 10 '26 | Proposed Sale | 40.53 | 187,943 | 7,617,817 | Nov 10 04:36 PM | |
| MAYUKH SUKHATME | Officer | Nov 10 '26 | Proposed Sale | 41.00 | 173,725 | 7,122,725 | Nov 10 04:28 PM | |
| MATTHEW ADAM GLINE | Officer | Nov 10 '26 | Proposed Sale | 41.00 | 164,136 | 6,729,576 | Nov 10 04:25 PM | |
| FRANK M TORTI | Officer | Nov 10 '26 | Proposed Sale | 41.08 | 1,234,964 | 50,732,321 | Nov 10 04:23 PM | |
| RICHARD PULIK | Officer | Nov 10 '26 | Proposed Sale | 41.20 | 125,000 | 5,150,575 | Nov 10 04:23 PM | |
| Venker Eric | President & Immunovant CEO | Nov 03 '26 | Sale | 36.31 | 200,000 | 7,262,000 | 999,154 | Nov 05 06:11 PM |
| Venker Eric | Officer | Nov 03 '26 | Proposed Sale | 36.31 | 200,000 | 7,262,568 | Nov 03 04:29 PM | |
| Venker Eric | President & Immunovant CEO | Oct 28 '26 | Sale | 36.59 | 200,000 | 7,318,000 | 1,199,154 | Oct 30 06:29 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | AUM: 125.56B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| XMMO | Invesco S&P MidCap Momentum ETF | AUM: 6.51B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | AUM: 26.08B |
| XBI | State Street SPDR S&P Biotech ETF | AUM: 10.59B |
| SPMD | State Street SPDR Portfolio S&P 400TM Mid Cap ETF | AUM: 19.06B |
News
latest 14 of 200- Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology (GlobeNewswire)
- Roivant Beats As LISRAYA Launch Lands At $31 Million, But Stocking And An Unsettled RA Path Complicate A Breakout Quarter (Earnings Whispers)
- Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update (GlobeNewswire)
- Roivant's First Post-Launch Report Puts Brepacitinib And A Crowded Catalyst Calendar To The Test (Earnings Whispers)
- Roivant Social Ventures Announced Support of No Patient Left Behind with Six-Figure Organizational Legacy Gift (GlobeNewswire)
- Roivant Sciences stock surges on positive uveitis trial data (Investing.com) +5.38%
- Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 (GlobeNewswire)
- Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU) (GlobeNewswire)
- IMVT, ROIV Stocks Slide As Argenx Sjögrens Trial Failure Hits Drug Class (Stocktwits)
- Roivant's Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss (InvestorsHub)
- Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus (GlobeNewswire)
- Podcast: key readouts from ESC and ERS (Pharmaceutical Technology)
- Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? (Stocktwits) +18.75%
- These 2 Biotech Stocks Hit Record Highs Today Whats Driving The Rallies? (Stocktwits)
Quarterly earnings
2026Q2 EPS -0.270 beat -0.367, from -0.202 a year earlier. Sales 35.12 beat 4.34, from 1.57 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2ended 2026-09-30 | 2026-11-09 08:30 | -0.270 | -0.367 | -0.270 | 35.12 | 4.34 | EPS -26.4% · sales +710.0% | vs 2025Q2, year-ago quarter · EPS +33.7% · sales +2135.6% | 11 | Open +1.52% vs SPY +0.91%. Close +4.60% vs SPY +2.37% |
| 2026Q1ended 2026-06-30 | 2026-08-06 08:30 | -0.335 | -0.300 | -0.263 | 1.44 | 2.06 | EPS +11.7% · sales -29.9% | vs 2025Q1, year-ago quarter · EPS +32.9% · sales -33.5% | 8 | Open -4.31% vs SPY +0.05%. Close +1.50% vs SPY -0.16% |
| 2025Q4ended 2026-03-31 | 2026-05-20 08:30 | 0.279 | -0.289 | 0.373 | 2.52 | 3.41 | EPS -196.5% · sales -26.2% | vs 2024Q4, year-ago quarter · EPS -196.3% · sales -66.7% | 12 EPS · 11 sales | Open +4.93% vs SPY +0.27%. Close +14.89% vs SPY +1.02% |
| 2025Q3ended 2025-12-31 | 2026-02-06 08:30 | -0.170 | -0.300 | -0.382 | 2.00 | 5.08 | EPS -43.4% · sales -60.6% | vs 2024Q3, year-ago quarter · EPS -16.6% · sales -77.8% | 9 EPS · 8 sales | Open +15.78% vs SPY +0.57%. Close +22.14% vs SPY +1.92% |
| 2025Q2ended 2025-09-30 | 2025-11-10 08:30 | -0.202 | -0.320 | -0.167 | 1.57 | 5.62 | EPS -36.9% · sales -72.0% | vs 2024Q2, year-ago quarter · EPS -29.2% · sales -64.9% | 10 EPS · 9 sales | Open -2.23% vs SPY +0.93%. Close +2.67% vs SPY +1.56% |
| 2025Q1ended 2025-06-30 | 2025-08-11 08:30 | -0.252 | -0.250 | -0.328 | 2.17 | 7.30 | EPS +0.8% · sales -70.3% | vs 2024Q1, year-ago quarter · EPS -309.8% · sales -96.1% | 8 EPS · 6 sales | Open -5.13% vs SPY +0.04%. Close -2.79% vs SPY -0.20% |
| 2024Q4ended 2025-03-31 | 2025-05-29 08:30 | -0.290 | -0.264 | -0.292 | 7.57 | 54.07 | EPS +10.1% · sales -86.0% | vs 2023Q4, year-ago quarter · EPS +52.6% · sales -73.8% | 7 | Open +1.69% vs SPY +0.91%. Close +6.40% vs SPY +0.39% |
| 2024Q3ended 2024-12-31 | 2025-02-10 08:30 | -0.203 | -0.253 | 0.234 | 9.02 | 5.00 | EPS -19.7% · sales +80.4% | vs 2023Q3, year-ago quarter · EPS -103.4% · sales -75.7% | 7 EPS · 6 sales | Open +4.78% vs SPY +0.54%. Close -0.92% vs SPY +0.68% |
| 2024Q2ended 2024-09-30 | 2024-11-12 08:30 | -0.285 | -0.247 | -0.313 | 4.48 | 45.92 | EPS +15.5% · sales -90.3% | vs 2023Q2, year-ago quarter · EPS +8.6% · sales -87.9% | 10 EPS · 8 sales | Open -0.21% vs SPY -0.01%. Close -1.44% vs SPY -0.31% |
| 2024Q1ended 2024-06-30 | 2024-08-08 08:30 | 0.120 | -0.243 | 0.122 | 55.13 | 30.72 | EPS -149.3% · sales +79.5% | vs 2023Q1, year-ago quarter · EPS -152.9% · sales +155.0% | 9 EPS · 7 sales | Open +4.23% vs SPY +1.01%. Close +6.69% vs SPY +2.31% |
| 2023Q4ended 2024-03-31 | 2024-05-30 08:30 | -0.190 | -0.264 | -0.188 | 28.93 | 31.01 | EPS -28.1% · sales -6.7% | vs 2022Q4, year-ago quarter · EPS -13.2% · sales +5.7% | 11 EPS · 10 sales | Open +4.29% vs SPY -0.30%. Close -3.17% vs SPY -0.66% |
| 2023Q3ended 2023-12-31 | 2024-02-13 08:30 | 6.030 | -0.309 | 6.035 | 37.14 | 31.77 | EPS -2051.5% · sales +16.9% | vs 2022Q3, year-ago quarter · EPS -1558.3% · sales +117.8% | 10 EPS · 11 sales | Open 0.00% vs SPY -1.29%. Close -0.64% vs SPY -1.38% |
| 2023Q2ended 2023-09-30 | 2023-11-13 08:30 | -0.263 | -0.288 | -0.395 | 37.10 | 27.11 | EPS -8.8% · sales +36.9% | vs 2022Q2, year-ago quarter · EPS -10.2% · sales +196.0% | 10 | - |
| 2023Q1ended 2023-06-30 | 2023-08-14 08:30 | -0.227 | -0.283 | -0.384 | 21.62 | 24.49 | EPS -20.0% · sales -11.7% | vs 2022Q1, year-ago quarter · EPS -52.8% · sales +400.7% | 9 EPS · 7 sales | - |
| 2022Q4ended 2023-03-31 | 2023-06-28 08:30 | -0.219 | -0.361 | -0.045 | 27.38 | 18.17 | EPS -39.4% · sales +50.7% | vs 2021Q4, year-ago quarter · EPS -19.3% · sales +196.8% | 9 EPS · 8 sales | - |
| 2022Q3ended 2022-12-31 | 2023-02-13 08:30 | -0.414 | -0.395 | -0.494 | 17.05 | 14.78 | EPS +4.8% · sales +15.4% | vs 2021Q3, year-ago quarter · EPS +0.9% · sales -29.9% | 8 EPS · 7 sales | - |
Annual earnings
2025FY EPS -0.540 beat -1.121, from -0.240 a year earlier. Sales 8.26 missed 9.09, from 29.05 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 2.856 | - | - | 5,612 | 14.01 |
| 2029FYestimate | - | 1.004 | - | - | 3,272 | 39.84 |
| 2028FYestimate | - | -0.539 | - | - | 1,600 | - |
| 2027FYestimate | - | -1.142 | - | - | 618.8 | - |
| 2026FYestimate | - | -1.178 | - | - | 148.05 | - |
| 2025FY | -0.540 | -1.121 | -0.540 | 8.26 | 9.09 | - |
| 2024FY | -0.240 | -0.521 | -0.237 | 29.05 | 141.38 | - |
| 2023FY | 5.230 | 5.221 | 5.233 | 124.8 | 181.74 | 2.02 |
| 2022FY | -1.151 | -1.588 | -1.416 | 61.28 | 52.28 | - |
| 2021FY | -1.171 | -1.180 | -1.262 | 55.29 | 52.87 | - |
Quarterly results
2026Q2 revenue 35.12, from 1.57 a year earlier. Operating margin -763.24%, from -19,505% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -1.18 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-10 | -1.18 | 0.0% |
| 2026FY | R | per share | 2026-11-10 | -1.14 | -3.4% |
| 2026FY | S | - | 2026-11-10 | 148.05 | +7.3% |
| 2026Q3 | E | per share | 2026-11-09 | -0.30 | -16.9% |
| 2026Q3 | R | per share | 2026-11-09 | -0.33 | -17.9% |
| 2026Q3 | S | per share | 2026-11-09 | 46.15 | +217.3% |
| 2026Q2 | S | per share | 2026-11-04 | 4.34 | +4.6% |
| 2026Q2 | E | per share | 2026-10-28 | -0.37 | -0.1% |
| 2026Q2 | R | per share | 2026-10-20 | -0.38 | 0.0% |
| 2026Q1 | E | per share | 2026-08-06 | -0.31 | +4.6% |
| 2026Q1 | R | per share | 2026-08-06 | -0.37 | +11.5% |
| 2026Q1 | S | per share | 2026-08-06 | 1.65 | -19.8% |
| 2025FY | E | per share | 2026-05-20 | -0.96 | -14.0% |
| 2025Q4 | E | per share | 2026-05-20 | -0.29 | -1.1% |
| 2025FY | R | per share | 2026-05-20 | -1.09 | -13.1% |
| 2025Q4 | R | per share | 2026-05-20 | -0.34 | +0.1% |
| 2025FY | S | per share | 2026-05-20 | 9.44 | +3.9% |
| 2025Q4 | S | per share | 2026-05-20 | 3.81 | +11.5% |
| 2025Q3 | E | per share | 2026-02-01 | -0.30 | 0.0% |
| 2025Q3 | R | per share | 2026-02-01 | -0.30 | 0.0% |
| 2025Q3 | S | per share | 2026-01-24 | 5.08 | 0.0% |
| 2025Q2 | E | per share | 2025-11-07 | -0.32 | +0.1% |
| 2025Q2 | S | per share | 2025-11-07 | 5.62 | +0.0% |
| 2025Q2 | R | per share | 2025-10-25 | -0.34 | 0.0% |
| 2025Q1 | E | per share | 2025-07-24 | -0.25 | +1.8% |
| 2025Q1 | R | per share | 2025-07-24 | -0.28 | +0.0% |
| 2025Q1 | S | per share | 2025-07-24 | 7.30 | -4.9% |
| 2024FY | E | per share | 2025-05-29 | -0.52 | -1.1% |
| 2024Q4 | E | per share | 2025-05-29 | -0.20 | -24.6% |
| 2024FY | R | per share | 2025-05-29 | -0.20 | -51.0% |
| 2024Q4 | R | per share | 2025-05-29 | -0.24 | -23.7% |
| 2024Q4 | S | per share | 2025-05-29 | 70.75 | +30.8% |
| 2024FY | S | - | 2025-05-29 | 155.17 | +9.8% |
| 2024Q3 | S | per share | 2025-01-27 | 5.00 | 0.0% |
| 2024Q3 | E | per share | 2025-01-26 | -0.25 | 0.0% |
| 2024Q3 | R | per share | 2025-01-26 | -0.31 | 0.0% |
| 2024Q2 | E | per share | 2024-11-06 | -0.25 | +6.0% |
| 2024Q2 | R | per share | 2024-11-06 | -0.25 | +4.3% |
| 2024Q2 | S | per share | 2024-11-06 | 45.92 | -5.6% |
| 2024Q1 | S | per share | 2024-08-06 | 30.72 | 0.0% |
| 2024Q1 | E | per share | 2024-07-18 | -0.24 | -0.5% |
| 2024Q1 | R | per share | 2024-06-19 | -0.26 | -1.6% |
| 2023Q4 | E | per share | 2024-05-28 | -0.26 | -2.3% |
| 2023Q4 | S | per share | 2024-05-28 | 31.01 | -1.2% |
| 2023FY | S | - | 2024-05-28 | 181.74 | -0.2% |
| 2023FY | E | per share | 2024-05-23 | 5.22 | +0.2% |
| 2023FY | R | per share | 2024-05-07 | 5.21 | 0.0% |
| 2023Q4 | R | per share | 2024-05-07 | -0.31 | 0.0% |
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -4.838 | 5.213 | -3.634 | -1.262 | -1.416 | 5.233 | -0.237 | -0.432 | -0.5589 | - |
| Sales USD millions | 2 | 68 | 24 | 55 | 61 | 33 | 29 | 8 | 41 | - |
| Shares million shares | 215 | 215 | 223 | 695 | 760 | 807 | 696 | 720 | - | 724 |
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.313 | 0.234 | -0.292 | -0.328 | -0.167 | -0.382 | 0.373 | -0.263 | -0.287 |
| Sales USD millions | 4 | 9 | 8 | 2 | 2 | 2 | 3 | 1 | 35 |
| Shares million shares | 733 | 720 | 696 | 682 | 690 | 710 | 720 | 723 | 724 |
Income statement, annual
| Metric | TTM | 2025FY3/31/2026 | 2024FY3/31/2025 | 2023FY3/31/2024 | 2022FY3/31/2023 | 2021FY3/31/2022 | 2020FY3/31/2021 | 2020FY12/31/2020 | 2019FY3/31/2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41.08 | 8.26-71.6% | 29.05-11.2% | 32.71-46.6% | 61.28+10.8% | 55.29+132.3% | 23.80-64.8% | 0.00-100.0% | 67.69 |
| Cost of Goods Sold Incl. D&A | 7.18 | 4.63-43.8% | 8.24-32.3% | 12.18-62.0% | 32.08+257.6% | 8.97+335.4% | 2.06+82.3% | 0.00-100.0% | 1.13 |
| Gross Profit | 33.90 | 3.63-82.6% | 20.81+1.3% | 20.54-29.7% | 29.20-37.0% | 46.32+113.1% | 21.74-67.3% | 0.00-100.0% | 66.56 |
| Selling, General and Administrative Excl. Other | 1,362.48 | 1,271.83+12.1% | 1,134.49+34.2% | 845.46-23.6% | 1,106.77-12.0% | 1,258.07+15.1% | 1,092.64+82.4% | 0.37-99.9% | 598.98 |
| Research and Development | 712.09 | 681.81+23.9% | 550.41+25.1% | 439.91-16.2% | 525.22+8.7% | 483.04-42.0% | 832.76+216.4% | - | 263.22 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
| Operating Income | -1,328.58 | -1,268.20 | -1,113.68 | -824.93 | -1,077.57 | -1,211.75 | -1,070.90 | -0.45 | -532.42 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 27.97+297.3% | 7.04+150.5% | 2.81-63.4% | - | 7.68 |
| Unusual Expense | -838.81 | -810.48 | -70.94-158.5% | 121.26-38.3% | 196.56-12.2% | 223.83 | -65.69-153.7% | -0.01-100.0% | 122.28 |
| Net Income Before Taxes | -297.18 | -264.58 | -681.59-114.9% | 4,567.86 | -1,224.83 | -923.75 | -898.55 | -0.37 | -560.99 |
| Income Taxes | 104.36 | 133.33+176.8% | 48.17+124.0% | 21.50+314.3% | 5.19+1302.7% | 0.37-78.1% | 1.69-76.3% | 0.02-99.7% | 7.12 |
| Consolidated Net Income | -401.54 | -397.91 | -729.76-116.1% | 4,546.35 | -1,230.02 | -924.12 | -900.23 | -0.39 | -568.11 |
| Net Income From Continuing Operations | -360.12 | -299.77 | -545.01-111.7% | 4,664.07 | -1,123.59 | -845.26 | -809.23 | -0.39 | -519.39 |
| Net Income | -360.12 | -299.77 | -171.98-104.0% | 4,348.93 | -1,009.03 | -845.26 | -809.23-172.1% | -0.39-100.0% | 1,122.73 |
| EPS (Recurring) per share | -1.31 | -1.25 | -0.31-105.8% | 5.34 | -1.22 | -1.03 | -3.84-168.4% | -0.01-100.2% | 5.61 |
| EPS (Basic, Before Extraordinaries) per share | -0.50 | -0.43 | -0.24-104.3% | 5.55 | -1.42 | -1.26 | -3.63-169.7% | -0.01-100.2% | 5.21 |
| EPS (Diluted) per share | -0.56 | -0.43 | -0.24-104.6% | 5.23 | -1.42 | -1.26 | -3.63-169.7% | -0.01-100.2% | 5.21 |
| EBITDA | -1,326.05 | -1,264.86 | -1,106.35 | -814.35 | -1,051.15 | - | - | -0.45 | - |
| Non-Operating Income (Expense) | 192.59 | 193.15-46.5% | 361.15-93.5% | 5,514.05+7036.1% | 77.27-85.1% | 518.87+374.0% | 109.47+7.9% | 0.08-99.9% | 101.41 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 289.85 | 273.47+19.8% | 228.33+44.8% | 157.71-8.3% | 172.05-58.3% | 412.42+565.0% | 62.02+25.4% | - | 49.46 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | 2.02 | - | - | - | - | - |
| Price To Sales Ratio ratio | 643.37 | 2,326.88 | 251.93 | 267.76 | 85.84 | 59.84 | - | - | - |
| Gross Margin % | 82.51 | 43.91 | 71.63 | 62.77 | 47.65 | 83.78 | 91.36 | - | 98.33 |
| Operating Margin % | -3,233.98 | -15,353.55 | -3,833.27 | -2,521.71 | -1,758.44 | -2,191.78 | -4,500.52 | - | -786.58 |
| Net Margin % | -876.58 | -3,629.19 | -591.96 | 13,294.18 | -1,646.59 | -1,528.89 | -3,400.86 | - | 1,658.66 |
| Shares Outstanding million shares | 723.69 | 720.35+3.5% | 695.94-13.7% | 806.68+6.1% | 760.14+9.4% | 694.98+212.1% | 222.67+3.4% | 51.34-76.2% | 215.35 |
| Market Capitalization | 28,975.19 | 28,975.19+302.4% | 7,199.71-15.2% | 8,493.62+51.7% | 5,597.19+63.7% | 3,418.84+4.2% | 3,280.42 | - | - |
Income statement, quarterly
| Metric | 2026Q29/30/2026 | 2026Q16/30/2026 | 2025Q43/31/2026 | 2025Q312/31/2025 | 2025Q29/30/2025 | 2025Q16/30/2025 | 2024Q43/31/2025 | 2024Q312/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 35.12+2136.9% | 1.44-33.6% | 2.52-66.7% | 2.00-77.8% | 1.57-64.9% | 2.17-96.1% | 7.57-73.8% | 9.02-75.7% |
| Cost of Goods Sold Incl. D&A | 3.95+283.5% | 0.88-29.6% | 0.96-39.6% | 1.39-36.8% | 1.03+347.8% | 1.25-80.8% | 1.59-77.9% | 2.20-66.7% |
| Gross Profit | 31.17+5672.2% | 0.56-39.1% | 1.56-73.9% | 0.61-91.1% | 0.54-87.3% | 0.92-98.1% | 5.98-72.5% | 6.82-77.7% |
| Selling, General and Administrative Excl. Other | 299.22-2.5% | 366.94+28.4% | 356.56+22.6% | 339.76+20.8% | 306.77-11.3% | 285.84+2.4% | 290.95+1.1% | 281.20-11.6% |
| Research and Development | 145.75-11.4% | 202.02+32.1% | 198.94+37.4% | 165.38+16.8% | 164.57+15.0% | 152.92+14.8% | 144.79+20.6% | 141.59+14.4% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -268.05 | -366.38 | -355.00 | -339.15 | -306.23 | -284.92 | -284.96 | -274.38 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Unusual Expense | -60.29 | -37.03-272.6% | -744.31 | 2.82-85.3% | -107.54 | 21.45 | -27.02 | 19.17-3.2% |
| Net Income Before Taxes | -166.34 | -294.56 | 454.10 | -290.37 | -159.04 | -269.26-483.9% | -203.05 | -234.51-104.6% |
| Income Taxes | -13.37-291.0% | -3.96-185.2% | 98.35+99.4% | 23.33 | 7.00-43.8% | 4.65-63.2% | 49.32 | -25.57-199.6% |
| Consolidated Net Income | -152.97 | -290.61 | 355.74 | -313.70 | -166.04 | -273.91-576.4% | -252.38 | -208.94-104.1% |
| Net Income From Continuing Operations | -207.38 | -189.84 | 302.99 | -265.89 | -113.52 | -223.35-334.4% | -206.47 | -157.64-103.1% |
| Net Income | -207.38 | -189.84 | 302.99 | -265.89-257.0% | -113.52 | -223.35-334.4% | -206.47 | 169.38-96.7% |
| EPS (Recurring) per share | -0.35 | -0.30 | -0.27 | -0.38-252.0% | -0.28 | -0.31 | -0.32 | 0.25-95.9% |
| EPS (Basic, Before Extraordinaries) per share | -0.29 | -0.26 | 0.43 | -0.38-265.2% | -0.17 | -0.33-353.8% | -0.29 | 0.23-96.4% |
| EPS (Diluted) per share | -0.29 | -0.26 | 0.37 | -0.38-265.2% | -0.17 | -0.33-375.0% | -0.29 | 0.23-96.2% |
| EBITDA | -267.44 | -365.79 | -354.36 | -338.46 | -305.31 | -283.82 | -283.58 | -272.44 |
| Non-Operating Income (Expense) | 41.41+4.4% | 34.79-6.3% | 64.78+18.0% | 51.61-12.6% | 39.65-42.0% | 37.11-79.5% | 54.89-7.6% | 59.03-98.9% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 62.64-3.1% | 65.84+1.4% | 92.74+40.6% | 68.63+9.9% | 64.64+18.0% | 64.92+63.7% | 65.95+78.7% | 62.47+45.0% |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | - | - | - | 2.09 |
| Price To Sales Ratio ratio | 643.37 | 3,386.66 | 2,724.01 | 1,136.13 | 506.80 | 330.00 | 93.66 | 87.64 |
| Gross Margin % | 88.75 | 38.70 | 61.98 | 30.42 | 34.31 | 42.30 | 79.02 | 75.58 |
| Operating Margin % | -763.22 | -25,408.11 | -14,087.10 | -16,966.13 | -19,492.87 | -13,130.05 | -3,764.40 | -3,042.59 |
| Net Margin % | -590.48 | -13,164.84 | 12,023.57 | -13,301.20 | -7,225.91 | -10,292.86 | -2,727.54 | 1,878.25 |
| Shares Outstanding million shares | 723.69+4.9% | 722.67+5.9% | 720.35+3.5% | 709.69-1.4% | 689.70-5.9% | 682.23-7.7% | 695.94-13.7% | 719.63-10.6% |
| Market Capitalization | 28,975.19+180.4% | 25,454.97+232.2% | 19,824.92+175.4% | 15,092.18+75.3% | 10,332.00+21.1% | 7,661.41-1.9% | 7,199.71-15.2% | 8,611.65-4.6% |
Balance sheet, annual
| Metric | 2025FY3/31/2026 | 2024FY3/31/2025 | 2023FY3/31/2024 | 2022FY3/31/2023 | 2021FY3/31/2022 | 2020FY3/31/2021 | 2020FY12/31/2020 | 2019FY3/31/2020 | 2018FY3/31/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4,295.69-12.1% | 4,889.25-24.8% | 6,498.02+286.4% | 1,681.82-18.5% | 2,064.30-3.2% | 2,132.74-2.4% | 1.70-99.9% | 2,185.48+157.3% | 849.55 |
| Short Term Receivables | 789.84 | 0.00 | 0.00-100.0% | 32.73 | 0.00-100.0% | 13.83-9.5% | 0.00-100.0% | 15.28+39.3% | 10.97 |
| Inventories | 0.00 | 0.00 | 0.00-100.0% | 2.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 81.86-26.1% | 110.81-52.6% | 233.81+187.7% | 81.27-1.2% | 82.22+103.4% | 40.42+118.7% | 0.28-98.5% | 18.48-94.3% | 324.95 |
| Total Current Assets | 5,167.38+3.3% | 5,000.06-25.7% | 6,731.83+274.3% | 1,798.59-16.2% | 2,146.52-1.9% | 2,186.99-1.5% | 1.98-99.9% | 2,219.24+87.2% | 1,185.48 |
| Net Property, Plant & Equipment | 92.40-8.6% | 101.08+70.4% | 59.32-35.8% | 92.34+6.2% | 86.95+12.9% | 77.03+4.2% | 0.00-100.0% | 73.93+565.4% | 11.11 |
| Total Investments and Advances | 415.88+33.8% | 310.83+21.5% | 255.92-18.7% | 314.61-6.2% | 335.56+12.4% | 298.47+68.4% | 410.80+131.8% | 177.22+4.4% | 169.80 |
| Long-Term Note Receivable | - | - | - | - | - | 100.00 | - | - | - |
| Intangible Assets | - | - | 137.84-4.9% | 144.88 | - | - | 0.00 | - | - |
| Deferred Tax Assets | 19.36 | - | - | - | - | - | 0.00 | - | - |
| Other Assets | 33.02+32.2% | 24.97-85.8% | 175.41+347.6% | 39.19+143.6% | 16.09-40.8% | 27.20+308.4% | 0.00-100.0% | 6.66-68.9% | 21.43 |
| Total Assets | 5,728.05+5.4% | 5,436.94-24.7% | 7,222.48+202.2% | 2,389.60-7.6% | 2,585.13-3.9% | 2,689.69+8.6% | 412.78-83.3% | 2,477.05+78.5% | 1,387.81 |
| Short Term Debt Incl. Current Port. of LT Debt | 11.15+13.3% | 9.84+9.7% | 8.97-83.5% | 54.50+378.1% | 11.40-7.4% | 12.31+57.0% | 0.00-100.0% | 7.84-63.0% | 21.18 |
| Accounts Payable | 18.00-24.0% | 23.69+68.9% | 14.03-62.9% | 37.83+9.4% | 34.58+68.3% | 20.55+99.3% | 0.00-100.0% | 10.31+65.5% | 6.23 |
| Income Tax Payable | 45.69+10778.6% | 0.42-95.7% | 9.77+1709.3% | 0.54 | - | 0.21-86.0% | 0.02-98.7% | 1.50+265.9% | 0.41 |
| Other Current Liabilities | 206.41+78.8% | 115.46-50.7% | 233.99+30.3% | 179.57+29.8% | 138.39-25.6% | 185.89+156.5% | 0.54-99.3% | 72.48-60.5% | 183.44 |
| Total Current Liabilities | 281.24+88.2% | 149.41-44.0% | 266.76-2.1% | 272.45+47.8% | 184.37-15.8% | 218.96+137.7% | 0.55-99.4% | 92.12-56.4% | 211.27 |
| Long Term Debt | 96.29+6.6% | 90.33+100.6% | 45.02-89.6% | 432.56+58.7% | 272.49+17.1% | 232.66+34.5% | 0.00-100.0% | 173.04+41.8% | 121.99 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 19.36 | - | - | - | - | - | 0.00 | - | - |
| Other Liabilities | 38.74+287.4% | 10.00-97.8% | 462.18+500.2% | 77.00+15.2% | 66.83-12.1% | 76.06-26.3% | 14.38-86.1% | 103.19-12.0% | 117.25 |
| Total Liabilities | 435.63+74.4% | 249.74-67.7% | 773.95-1.0% | 782.02+49.3% | 523.70-0.8% | 527.69+43.3% | 14.93-95.9% | 368.36-18.2% | 450.51 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 4,527.37-3.4% | 4,687.60-21.5% | 5,968.58+415.5% | 1,157.77-30.1% | 1,656.94-12.7% | 1,897.79-6.6% | 397.85-80.4% | 2,032.16+183.4% | 716.95 |
| Total Shareholders Equity | 4,527.37-3.4% | 4,687.60-21.5% | 5,968.58+415.5% | 1,157.77-30.1% | 1,656.94-12.7% | 1,897.79-6.6% | 397.85-80.4% | 2,032.16+183.4% | 716.95 |
| Accumulated Minority Interest | 765.04+53.1% | 499.59+4.1% | 479.95+6.7% | 449.82+11.2% | 404.49+53.1% | 264.22+245.3% | 0.00-100.0% | 76.53-65.3% | 220.35 |
| Total Equity | 5,292.41+2.0% | 5,187.20-19.6% | 6,448.53+301.1% | 1,607.59-22.0% | 2,061.43-4.7% | 2,162.01+2.5% | 397.85-81.1% | 2,108.70+125.0% | 937.30 |
| Total Liabilities & Stockholders Equity | 5,728.05+5.4% | 5,436.94-24.7% | 7,222.48+202.2% | 2,389.60-7.6% | 2,585.13-3.9% | 2,689.69+8.6% | 412.78-83.3% | 2,477.05+78.5% | 1,387.81 |
| Book Value Per Share per share | 6.28-6.8% | 6.74-8.9% | 7.40+386.8% | 1.52-36.1% | 2.38-72.1% | 8.52-9.7% | 7.75-17.9% | 9.44+183.5% | 3.33 |
| Tangible Book Value Per Share per share | 6.28-6.8% | 6.74-8.9% | 7.40+456.4% | 1.33-44.1% | 2.38-72.1% | 8.52-9.7% | 7.75-17.9% | 9.44+183.5% | 3.33 |
| Full-Time Employees people | 721-3.9% | 750-17.4% | 908+0.4% | 904+4.8% | 863+39.2% | 620 | 2 | - | - |
| Price to Book Ratio ratio | 7.20 | 1.40 | 1.39 | 4.85 | 2.07 | 1.76 | - | - | - |
| Return on Assets % | -5.37 | -8.61 | 97.05 | -45.17 | -32.05 | -31.32 | - | -26.88 | - |
| Return on Equity % | -6.51 | -10.23 | 130.90 | -79.84 | -47.56 | -41.18 | - | -37.79 | - |
| Return on Invested Capital % | -6.48 | -3.60 | 72.32 | -63.45 | -43.81 | -37.98 | -0.10 | 54.44 | -124.20 |
| Quick Ratio ratio | 18.37 | 33.47 | 25.24 | 6.59 | 11.64 | 9.99 | 3.58 | 24.09 | 5.61 |
| Current Ratio ratio | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 | 9.99 | 3.58 | 24.09 | 5.61 |
Cash flow, annual
| Metric | TTM | 2025FY3/31/2026 | 2024FY3/31/2025 | 2023FY3/31/2024 | 2022FY3/31/2023 | 2021FY3/31/2022 | 2020FY3/31/2021 | 2020FY12/31/2020 | 2019FY3/31/2020 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -385.77 | -397.91 | -356.73-108.4% | 4,231.21 | -1,115.46 | -924.12 | -900.23-189.1% | -0.39-100.0% | 1,010.32 |
| Depreciation | 2.53 | 3.35-54.3% | 7.33-30.7% | 10.58-60.0% | 26.42 | - | - | - | - |
| Other Funds (Non Cash) | 244.06 | 266.01 | -413.00 | -5,026.09-2200.3% | 239.30+3.7% | 230.67-16.4% | 275.87 | -0.09 | -1,787.44 |
| Funds from Operations | -139.18 | -128.55 | -762.40 | -784.30 | -849.74 | -693.45 | -624.36 | -0.47 | -777.13 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 102.79 | -621.80 | -77.05-504.7% | 19.04+200.3% | 6.34-59.7% | 15.72-78.1% | 71.94+370.2% | 0.22-98.6% | 15.30 |
| Income Taxes Payable | - | 85.05 | - | - | - | - | - | 0.02 | - |
| Cash from Operating Activities | -36.39 | -750.35 | -839.45 | -765.27 | -843.39 | -677.73 | -552.42 | -0.25 | -761.83 |
| Capital Expenditures | 3.05 | -8.21 | -4.60 | -1.38 | -12.69 | -17.44 | -5.81 | 0.00 | -4.92 |
| Net Assets From Acquisitions | -4.42 | -4.42 | -31.22 | -84.48 | -6.71 | 0.00 | 0.00 | 0.00 | -0.50 |
| Sale of Fixed Assets and Businesses | 20.88 | 0.00-100.0% | 260.59+448.6% | 47.50 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 1,772.19 |
| Purchase or Sale of Investments | -229.99 | -1,488.56 | -1,991.13-138.0% | 5,233.40 | 0.00-100.0% | 320.17 | -28.25 | -410.72 | -51.94 |
| Purchase of Investments | -3,136.23 | -4,795.85 | -4,061.52 | 0.00 | 0.00 | 0.00 | -28.25 | -410.72 | -68.38 |
| Sale Or Maturity of Investments | 2,906.24 | 3,307.30+59.7% | 2,070.39-60.4% | 5,233.40 | 0.00-100.0% | 320.17 | 0.00-100.0% | 0.00-100.0% | 16.44 |
| Other Uses | -1.61 | 0.00 | 0.00 | 0.00 | -140.14 | 0.00 | -19.09 | 0.00 | -20.05 |
| Other Sources | 818.85 | 818.85+1023462.5% | 0.08-99.1% | 8.59-92.5% | 115.26+20482.1% | 0.56-97.4% | 21.44 | 0.00 | 0.00 |
| Cash from Investing Activities | 606.76 | -682.33 | -1,766.29-133.9% | 5,203.62 | -44.27-114.6% | 303.30 | -31.70-101.9% | -410.72-124.2% | 1,694.79 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | -6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 73.65 | 143.61 | -1,129.83-328.8% | 493.82+29.0% | 382.84+22.1% | 313.42-31.4% | 456.55+175.4% | 412.13+148.6% | 165.75 |
| Repurchase of Common Pref Stock | -392.41 | -319.50 | -1,293.23 | 0.00 | 0.00 | 0.00 | -0.11 | 0.00 | -1,188.46 |
| Sale of Common Pref Stock | 466.06 | 463.11+183.4% | 163.41-66.9% | 493.82+29.0% | 382.84+22.1% | 313.42-31.4% | 456.66-66.3% | 412.13-69.6% | 1,354.21 |
| Proceedsfrom Stock Options | 193.47 | 193.60+71.7% | 112.78-74.3% | 438.56+15.5% | 379.71+21.2% | 313.42-31.2% | 455.76-66.3% | 412.13-69.5% | 1,352.80 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | -52.75 | -30.70-124.1% | 127.50 | -5.49 | 0.00 | 0.00 | -32.06 |
| Change in Long Term Debt | 0.00 | 0.00 | -52.75 | -30.70-124.1% | 127.50 | -5.49 | 0.00 | 0.00 | -32.06 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 157.65+879.2% | 16.10 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | -52.75 | -30.70 | -30.14 | -21.59 | 0.00 | 0.00 | -32.06 |
| Net Financing Active Other Cash Flow | -244.96 | -9.37 | -37.22 | -37.76 | -10.88 | -1.15 | 0.00-100.0% | 0.53-99.4% | 83.48 |
| Other Financing Activities Uses | -284.21 | -48.62 | -37.22 | -37.76 | -10.88 | -1.15 | 0.00 | 0.00 | -0.30 |
| Cash from Financing Activities | -171.31 | 134.24 | -1,219.79-390.9% | 419.36-16.0% | 499.46+62.8% | 306.79-32.8% | 456.55+110.2% | 412.66+90.0% | 217.16 |
| Exchange Rate Effect | 3.36 | 3.77+402.7% | 0.75+21.0% | 0.62-90.1% | 6.28 | - | - | - | - |
| Net Change in Cash | 402.42 | -1,294.68 | -3,824.79-178.7% | 4,858.34 | -381.92 | -67.64 | -127.58-111.1% | 1.70-99.9% | 1,150.12 |
| Free Cash Flow | -33.34 | -758.56 | -844.05 | -766.65 | -856.08 | -695.16 | -558.23 | -0.25 | -766.75 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q29/30/2026 | 2026Q16/30/2026 | 2025Q43/31/2026 | 2025Q312/31/2025 | 2025Q29/30/2025 | 2025Q16/30/2025 | 2024Q43/31/2025 | 2024Q312/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4,207.59-4.1% | 3,846.28-14.6% | 4,295.69-12.1% | 4,532.59-12.0% | 4,388.09-18.6% | 4,505.41-20.7% | 4,889.25-25.3% | 5,149.61-22.9% |
| Short Term Receivables | 21.60 | 793.23 | 789.84 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 143.78+224.6% |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Other Current Assets | 126.36+2.3% | 102.58-7.0% | 81.86-26.1% | 127.30+80.4% | 123.55-68.2% | 110.34+61.4% | 110.81+52.4% | 70.58-13.1% |
| Total Current Assets | 4,355.54-3.5% | 4,742.08+2.7% | 5,167.38+3.3% | 4,659.89-13.1% | 4,511.65-22.2% | 4,615.75-23.1% | 5,000.06-25.7% | 5,363.97-21.2% |
| Net Property, Plant & Equipment | 88.26-20.3% | 90.21-11.5% | 92.40-8.6% | 97.01-7.1% | 110.80+95.6% | 101.94+61.4% | 101.08+53.3% | 104.46+51.9% |
| Total Investments and Advances | 512.23+21.9% | 452.51+55.1% | 415.88+33.8% | 441.80+48.3% | 420.21+31.5% | 291.71+7.1% | 310.83+20.9% | 297.93+19.5% |
| Deferred Tax Assets | - | - | 19.36 | - | - | - | - | - |
| Other Assets | 19.79-0.8% | 21.69-6.5% | 33.02+32.2% | 26.67+2.6% | 19.94-30.6% | 23.20-1.0% | 24.97-16.0% | 25.99-30.5% |
| Total Assets | 4,975.82-1.7% | 5,306.49+5.4% | 5,728.05+5.4% | 5,225.37-9.8% | 5,062.60-18.4% | 5,032.60-22.5% | 5,436.94-24.7% | 5,792.35-20.8% |
| Short Term Debt Incl. Current Port. of LT Debt | 13.78+53.1% | 12.38+31.7% | 11.15+13.3% | 10.44+6.1% | 9.00-5.5% | 9.40-56.3% | 9.84-55.0% | 9.84-82.5% |
| Accounts Payable | 11.30-25.0% | 25.08+117.1% | 18.00-24.0% | 13.29-43.9% | 15.06-40.1% | 11.55-58.4% | 23.69-55.5% | 23.71-32.7% |
| Income Tax Payable | 59.08 | 74.18 | 45.69+10778.6% | 7.17+1136.2% | - | - | 0.42-96.0% | 0.58-97.7% |
| Other Current Liabilities | 195.75+78.3% | 171.95+85.1% | 206.41+78.8% | 121.07+12.8% | 109.79-78.7% | 92.91-34.7% | 115.46-36.3% | 107.36-16.3% |
| Total Current Liabilities | 279.91+109.1% | 283.60+149.1% | 281.24+88.2% | 151.96+7.4% | 133.86-75.9% | 113.87-47.0% | 149.41-44.0% | 141.48-42.2% |
| Long Term Debt | 92.79+3.3% | 94.77+5.0% | 96.29+6.6% | 98.50+8.9% | 89.84+108.0% | 90.29-74.7% | 90.33-81.1% | 90.48-79.9% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | 19.36 | - | - | - | - | - |
| Other Liabilities | 7.40-77.9% | 6.25-50.2% | 38.74+287.4% | 0.68-97.2% | 33.44+26.0% | 12.54-56.1% | 10.00-65.9% | 24.41-25.6% |
| Total Liabilities | 380.10+47.8% | 384.62+77.5% | 435.63+74.4% | 251.14-2.0% | 257.14-58.9% | 216.70-64.0% | 249.74-67.7% | 256.38-64.8% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 4,020.32-7.8% | 4,231.27-2.6% | 4,527.37-3.4% | 4,269.26-17.7% | 4,362.33-15.3% | 4,345.63-20.0% | 4,687.60-21.5% | 5,189.47-14.8% |
| Total Shareholders Equity | 4,020.32-7.8% | 4,231.27-2.6% | 4,527.37-3.4% | 4,269.26-17.7% | 4,362.33-15.3% | 4,345.63-20.0% | 4,687.60-21.5% | 5,189.47-14.8% |
| Accumulated Minority Interest | 575.40+29.8% | 690.60+46.9% | 765.04+53.1% | 704.97+103.5% | 443.13+3.8% | 470.27+2.2% | 499.59+4.1% | 346.50-30.0% |
| Total Equity | 4,595.72-4.4% | 4,921.87+2.2% | 5,292.41+2.0% | 4,974.22-10.1% | 4,805.46-13.9% | 4,815.91-18.3% | 5,187.20-19.6% | 5,535.97-15.9% |
| Total Liabilities & Stockholders Equity | 4,975.82-1.7% | 5,306.49+5.4% | 5,728.05+5.4% | 5,225.37-9.8% | 5,062.60-18.4% | 5,032.60-22.5% | 5,436.94-24.7% | 5,792.35-20.8% |
| Book Value Per Share per share | 5.56-12.0% | 5.86-8.0% | 6.28-6.8% | 6.02-16.5% | 6.32-10.1% | 6.37-13.3% | 6.74-8.9% | 7.21-4.8% |
| Tangible Book Value Per Share per share | 5.56-12.0% | 5.86-8.0% | 6.28-6.8% | 6.02-16.5% | 6.32-10.1% | 6.37-11.2% | 6.74-6.8% | 7.21-2.3% |
| Full-Time Employees people | - | - | 721-3.9% | - | - | - | 750-17.4% | - |
| Price to Book Ratio ratio | 7.20 | 5.63 | 4.60 | 3.43 | 2.38 | 1.67 | 1.40 | 1.68 |
| Return on Assets % | -7.17 | -5.15 | -5.37 | -14.69 | -12.44 | -13.44 | -7.20 | -6.11 |
| Return on Equity % | -8.59 | -6.21 | -6.51 | -17.11 | -14.73 | -15.84 | -8.56 | -7.10 |
| Return on Invested Capital % | -5.04 | -4.39 | 6.55 | -6.09 | -2.55 | -5.04 | -4.32 | 3.21 |
| Quick Ratio ratio | 15.56 | 16.72 | 18.37 | 30.66 | 33.70 | 40.54 | 33.47 | 37.91 |
| Current Ratio ratio | 15.56 | 16.72 | 18.37 | 30.66 | 33.70 | 40.54 | 33.47 | 37.91 |
Cash flow, quarterly
| Metric | 2026Q29/30/2026 | 2026Q16/30/2026 | 2025Q43/31/2026 | 2025Q312/31/2025 | 2025Q29/30/2025 | 2025Q16/30/2025 | 2024Q43/31/2025 | 2024Q312/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -137.21 | -290.61 | 355.74 | -313.70-365.7% | -166.04 | -273.91-576.4% | -252.38 | 118.08-97.7% |
| Depreciation | 0.60-34.8% | 0.60-45.5% | 0.64-55.2% | 0.69-64.4% | 0.92 | 1.10-77.5% | 1.43-72.6% | 1.94-6.3% |
| Other Funds (Non Cash) | 3.84 | 52.20-50.6% | 80.88+84.2% | 107.15 | -27.62-840.5% | 105.60 | 43.90-17.0% | -274.16 |
| Funds from Operations | -132.77 | -237.81 | 437.26 | -205.86 | -192.74 | -167.22 | -207.05 | -154.15 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 727.19+10171.0% | -32.70 | -601.08-1843.3% | 9.37 | 7.08-31.3% | -37.17 | 34.48+116.0% | -53.10-350.5% |
| Income Taxes Payable | -15.11 | -10.18 | - | - | - | - | - | - |
| Cash from Operating Activities | 594.42 | -270.50 | -163.82 | -196.48 | -185.66 | -204.38 | -172.56 | -207.25 |
| Capital Expenditures | -0.21 | -0.42 | -1.26 | 4.93 | -7.85 | -4.04 | -0.81 | -1.83 |
| Net Assets From Acquisitions | 0.00 | 0.00 | -4.42 | 0.00 | 0.00 | 0.00 | -0.07 | -31.15 |
| Sale of Fixed Assets and Businesses | 20.88 | 0.00 | -39.25 | 39.25-78.9% | 0.00-100.0% | 0.00 | -35.39 | 185.59-96.5% |
| Purchase or Sale of Investments | 23.47-81.7% | 281.68 | -642.20-157.8% | 107.05-64.5% | 128.27 | -1,081.68 | 1,110.39-78.8% | 301.46 |
| Purchase of Investments | -832.28 | -286.51 | -1,003.73 | -1,013.71 | -976.73 | -1,801.68 | 0.00 | -658.54 |
| Sale Or Maturity of Investments | 855.75-22.6% | 568.19-21.1% | 361.53-67.4% | 1,120.77+16.7% | 1,105.00 | 720.00 | 1,110.39-78.8% | 960.00 |
| Other Uses | -1.61 | 0.00 | 2.52 | -2.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 818.85+1023462.5% | 0.00 | 0.00 | 0.00 | 0.08-99.0% | 0.00 |
| Cash from Investing Activities | 42.54-64.7% | 281.26 | 134.24-87.5% | 148.72-67.2% | 120.42 | -1,085.72 | 1,074.19+15400.6% | 454.07-91.3% |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -49.05-171.0% | -130.07 | -60.02 | 312.80 | 69.07 | -178.24 | -169.69-4749.0% | -215.23-186.9% |
| Repurchase of Common Pref Stock | -74.47 | -206.73 | -111.21 | 0.00 | 0.00 | -208.29 | -295.44 | -243.35 |
| Sale of Common Pref Stock | 25.42-63.2% | 76.65+155.0% | 51.19-59.3% | 312.80+1012.8% | 69.07+850.1% | 30.06+1224.2% | 125.75+3345.2% | 28.11-88.6% |
| Proceedsfrom Stock Options | 0.00-100.0% | 0.64 | -1.16-101.0% | 193.99 | 0.77+18.5% | 0.00 | 112.13 | 0.00-100.0% |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.09 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.09 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.09 |
| Net Financing Active Other Cash Flow | -200.16 | -51.44 | 30.50 | -23.86 | -6.48 | -9.53 | -7.46 | -8.63 |
| Other Financing Activities Uses | -200.16 | -51.44 | -8.75 | -23.86 | -6.48 | -9.53 | -7.46 | -8.63 |
| Cash from Financing Activities | -249.21-498.2% | -181.51 | -29.53 | 288.94 | 62.59 | -187.77 | -177.15 | -272.95-215.3% |
| Exchange Rate Effect | 1.29+6.6% | 0.32-60.5% | 1.32 | 0.43 | 1.21-76.0% | 0.81 | -0.49 | -1.07 |
| Net Change in Cash | 389.04 | -170.44 | -57.79-108.0% | 241.61 | -1.45 | -1,477.05 | 723.99 | -27.20-100.5% |
| Free Cash Flow | 594.21 | -270.92 | -165.08 | -191.55 | -193.51 | -208.42 | -173.38 | -209.08 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Pharmaceutical Preparations | 29.05 | 8.26 | -71.6% | 100.0% |
| Total | 29.05 | 8.26 | -71.6% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United Kingdom | 29.05 | 8.26 | -71.6% | 100.0% |
| Total | 29.05 | 8.26 | -71.6% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 8.68% | 45.5M | 524.3M | 7.60M |
| 2026-10-15 | 7.69% | 40.3M | 524.3M | 7.05M |
| 2026-09-30 | 7.50% | 39.3M | 524.1M | 7.03M |
| 2026-09-15 | 6.90% | 36.2M | 524.1M | 6.83M |
| 2026-08-31 | 6.40% | 33.5M | 524.1M | 6.10M |
| 2026-08-14 | 5.84% | 30.6M | 524.1M | 6.03M |
| 2026-07-31 | 5.65% | 35.2M | 623.1M | 5.78M |
| 2026-07-15 | 7.09% | 36.7M | 517.6M | 6.02M |
| 2026-06-30 | 6.42% | 33.2M | 517.6M | 5.93M |
| 2026-06-15 | 6.43% | 33.2M | 517.1M | 5.60M |
| 2026-05-29 | 7.02% | 36.2M | 516.3M | 5.95M |
| 2026-05-15 | 5.30% | 27.4M | 516.2M | 5.41M |
| 2026-04-30 | 5.44% | 27.1M | 497.5M | 6.13M |
| 2026-04-15 | 5.01% | 24.5M | 488.4M | 5.97M |
| 2026-03-31 | 5.10% | 24.9M | 488.4M | 6.38M |
| 2026-03-13 | 4.79% | 23.4M | 488.4M | 6.90M |
| 2026-02-27 | 4.80% | 23.5M | 488.4M | 6.99M |
| 2026-02-13 | 4.49% | 22.3M | 495.9M | 7.19M |
| 2026-01-30 | 5.32% | 23.3M | 437.5M | 7.25M |
| 2026-01-15 | 5.61% | 24.5M | 437.5M | 7.99M |
Option chain
Expiry 2026-11-20 · underlying 40.00, quoted 13 Nov 08:06 ET · ATM 40.00
Option quotes 12 Nov 14:44 ET. A date on a row is older than the last session (12 Nov). 64 rows.
Implied move 6.56% into expiry (call 1.250 + put 1.375 = 2.625 on 40.00)
Put/call open interest 0.38 (2,492 puts / 6,580 calls) · Put/call volume 0.00 (0 puts / 351 calls)
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 28 Jul | 15.00 | ITM | 23.30 | 27.10 | 19.00 | 0.00 | 700.9% +129.0 | 0 | 0 | 0 | 0.944 | -0.242 | 0.007 |
| put 6 Apr | OTM | 0.00 | 2.15 | 0.60 | 0.00 | 571.6% 0.0 | 1 | 0 | 0 | -0.056 | -0.240 | 0.007 | |
| call 8 Sep | 20.00 | ITM | 18.40 | 22.20 | 21.17 | 0.00 | 536.0% +109.5 | 0 | 0 | 0 | 0.923 | -0.233 | 0.008 |
| put 1 Jan | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 426.3% 0.0 | 0 | 0 | 0 | -0.077 | -0.231 | 0.008 | |
| call 1 Jan | 21.00 | ITM | 17.30 | 21.20 | 0.00 | 0.00 | 506.7% +104.5 | 0 | 0 | 0 | 0.918 | -0.230 | 0.009 |
| put 29 Apr | OTM | 0.00 | 1.15 | 1.55 | 0.00 | 402.1% 0.0 | 11 | 0 | 0 | -0.082 | -0.228 | 0.009 | |
| call 1 Jan | 22.00 | ITM | 16.30 | 20.20 | 0.00 | 0.00 | 478.8% +94.5 | 0 | 0 | 0 | 0.911 | -0.234 | 0.009 |
| put 29 Apr | OTM | 0.00 | 2.20 | 1.80 | 0.00 | 384.2% 0.0 | 7 | 0 | 0 | -0.089 | -0.232 | 0.009 | |
| call 1 Jan | 23.00 | ITM | 15.40 | 19.20 | 0.00 | 0.00 | 452.2% +90.3 | 0 | 0 | 0 | 0.905 | -0.231 | 0.010 |
| put 1 Jan | OTM | 0.00 | 2.20 | 0.00 | 0.00 | 361.8% 0.0 | 0 | 0 | 0 | -0.095 | -0.228 | 0.010 | |
| call 15 Oct | 24.00 | ITM | 14.40 | 18.20 | 10.29 | 0.00 | 426.7% +86.4 | 1 | 0 | 0 | 0.899 | -0.227 | 0.010 |
| put 1 Jan | OTM | 0.00 | 2.20 | 0.00 | 0.00 | 337.0% 0.0 | 0 | 0 | 0 | -0.098 | -0.218 | 0.010 | |
| call 1 Jan | 25.00 | ITM | 14.00 | 17.20 | 0.00 | 0.00 | 402.3% +82.7 | 0 | 0 | 0 | 0.892 | -0.223 | 0.011 |
| put 1 Jan | OTM | 0.00 | 2.20 | 0.00 | 0.00 | 319.6% 0.0 | 0 | 0 | 0 | -0.108 | -0.221 | 0.011 | |
| call 1 Jan | 26.00 | ITM | 12.50 | 16.30 | 0.00 | 0.00 | 386.2% +86.6 | 0 | 0 | 0 | 0.885 | -0.219 | 0.011 |
| put 27 Mar | OTM | 0.00 | 1.35 | 4.30 | 0.00 | 299.6% 0.0 | 150 | 0 | 0 | -0.115 | -0.216 | 0.011 | |
| call 1 Jan | 27.00 | ITM | 11.60 | 15.30 | 0.00 | 0.00 | 363.3% +82.9 | 0 | 0 | 0 | 0.878 | -0.215 | 0.012 |
| put 20 Oct | OTM | 0.00 | 1.35 | 0.35 | 0.00 | 280.4% 0.0 | 201 | 0 | 0 | -0.122 | -0.212 | 0.012 | |
| call 24 Apr | 28.00 | ITM | 10.60 | 14.30 | 5.23 | 0.00 | 341.0% +79.3 | 1 | 0 | 0 | 0.869 | -0.210 | 0.012 |
| put 1 Jan | OTM | 0.00 | 2.25 | 0.00 | 0.00 | 261.6% 0.0 | 0 | 0 | 0 | -0.131 | -0.207 | 0.012 | |
| call 20 Oct | 29.00 | ITM | 9.20 | 13.30 | 6.74 | 0.00 | 319.4% +76.0 | 101 | 0 | 0 | 0.860 | -0.205 | 0.013 |
| put 1 Jan | OTM | 0.00 | 2.25 | 0.00 | 0.00 | 243.5% 0.0 | 0 | 0 | 0 | -0.140 | -0.202 | 0.013 | |
| call | 30.00 | ITM | 8.80 | 12.30 | 10.80 | +4.81 | 298.4% +72.7 | 211 | 300 | 300 | 0.850 | -0.199 | 0.014 |
| put 3 Nov | OTM | 0.00 | 1.20 | 0.35 | 0.00 | 225.7% 0.0 | 350 | 0 | 0 | -0.150 | -0.196 | 0.014 | |
| call 26 Jun | 31.00 | ITM | 7.30 | 11.40 | 6.42 | 0.00 | 283.9% +65.2 | 151 | 0 | 0 | 0.831 | -0.209 | 0.015 |
| put 10 Nov | OTM | 0.00 | 2.30 | 0.35 | 0.00 | 218.6% 0.0 | 8 | 0 | 0 | -0.169 | -0.205 | 0.015 | |
| call 21 Oct | 32.00 | ITM | 6.90 | 10.40 | 5.00 | 0.00 | 263.5% +62.4 | 1 | 0 | 0 | 0.818 | -0.201 | 0.015 |
| put 10 Nov | OTM | 0.00 | 2.30 | 0.40 | 0.00 | 201.0% 0.0 | 3 | 0 | 0 | -0.182 | -0.198 | 0.015 | |
| call 22 Oct | 33.00 | ITM | 5.70 | 9.40 | 6.00 | 0.00 | 243.5% +59.7 | 8 | 0 | 0 | 0.803 | -0.193 | 0.016 |
| put 21 Oct | OTM | 0.00 | 2.35 | 0.85 | 0.00 | 183.7% 0.0 | 6 | 0 | 0 | -0.197 | -0.190 | 0.016 | |
| call 16 Oct | 34.00 | ITM | 4.50 | 8.40 | 2.32 | 0.00 | 223.7% +57.1 | 2 | 0 | 0 | 0.785 | -0.185 | 0.017 |
| put 3 Nov | OTM | 0.00 | 1.75 | 1.07 | 0.00 | 166.6% 0.0 | 304 | 0 | 0 | -0.215 | -0.181 | 0.017 | |
| call 6 Nov | 35.00 | ITM | 4.70 | 7.50 | 3.97 | 0.00 | 209.1% +59.6 | 19 | 0 | 0 | 0.765 | -0.175 | 0.018 |
| put 9 Nov | OTM | 0.00 | 1.35 | 0.39 | 0.00 | 149.5% 0.0 | 1,316 | 0 | 0 | -0.235 | -0.171 | 0.018 | |
| call 4 Nov | 36.00 | ITM | 2.90 | 6.50 | 2.40 | 0.00 | 189.4% +49.1 | 48 | 0 | 0 | 0.732 | -0.175 | 0.019 |
| put 9 Nov | OTM | 0.00 | 1.50 | 0.63 | 0.00 | 140.2% 0.0 | 4 | 0 | 0 | -0.268 | -0.171 | 0.019 | |
| call | 37.00 | ITM | 1.70 | 4.20 | 3.99 | -1.08 | 106.5% -35.4 | 4,597 | 40 | 10 | 0.685 | -0.191 | 0.021 |
| put 15 Oct | OTM | 0.00 | 2.55 | 4.40 | 0.00 | 146.7% +4.9 | 4 | 0 | 0 | -0.315 | -0.187 | 0.021 | |
| call | 38.00 | ITM | 1.70 | 4.90 | 3.78 | +0.93 | 135.6% +6.1 | 36 | 5 | 5 | 0.644 | -0.183 | 0.022 |
| put 11 Nov | OTM | 0.00 | 2.65 | 1.01 | 0.00 | 127.5% -2.0 | 3 | 0 | 0 | -0.356 | -0.179 | 0.022 | |
| call 11 Nov | 39.00 | ITM | 0.90 | 3.50 | 3.25 | 0.00 | 128.5% +13.2 | 132 | 0 | 0 | 0.594 | -0.170 | 0.023 |
| put 9 Nov | OTM | 0.00 | 2.00 | 1.17 | 0.00 | 107.5% -7.8 | 70 | 0 | 0 | -0.406 | -0.165 | 0.023 | |
| call 10 Nov | 40.00 | ATM | 0.00 | 2.50 | 2.20 | 0.00 | 106.6% -5.9 | 905 | 0 | 0 | 0.534 | -0.169 | 0.023 |
| put 20 Oct | ATM | 0.00 | 2.75 | 5.00 | 0.00 | 118.4% +5.9 | 42 | 0 | 0 | -0.466 | -0.165 | 0.023 | |
| call 10 Nov | 41.00 | OTM | 0.05 | 2.45 | 1.53 | 0.00 | 123.2% +10.1 | 82 | 0 | 0 | 0.475 | -0.170 | 0.023 |
| put 11 Nov | ITM | 0.45 | 2.80 | 1.80 | 0.00 | 96.5% -16.7 | 4 | 0 | 0 | -0.525 | -0.166 | 0.023 | |
| call 9 Nov | 42.00 | OTM | 0.00 | 2.70 | 1.30 | 0.00 | 107.3% -2.5 | 46 | 0 | 0 | 0.413 | -0.162 | 0.023 |
| put 1 Jan | ITM | 1.15 | 3.90 | 0.00 | 0.00 | 117.2% +7.4 | 0 | 0 | 0 | -0.587 | -0.157 | 0.023 | |
| call | 43.00 | OTM | 0.00 | 1.30 | 0.50 | -0.20 | 103.8% -1.3 | 23 | 6 | 1 | 0.349 | -0.147 | 0.022 |
| put 8 Oct | ITM | 1.20 | 4.50 | 9.71 | 0.00 | 114.2% +9.1 | 8 | 0 | 0 | -0.651 | -0.142 | 0.022 | |
| call 1 Jan | 44.00 | OTM | 0.00 | 2.35 | 0.00 | 0.00 | 116.7% 0.0 | 0 | 0 | 0 | 0.320 | -0.157 | 0.021 |
| put 1 Jan | ITM | 2.10 | 5.50 | 0.00 | 0.00 | 127.5% +10.7 | 0 | 0 | 0 | -0.680 | -0.152 | 0.021 | |
| call 6 Nov | 45.00 | OTM | 0.00 | 2.30 | 0.69 | 0.00 | 128.7% 0.0 | 206 | 0 | 0 | 0.299 | -0.168 | 0.020 |
| put 1 Jan | ITM | 3.00 | 6.80 | 0.00 | 0.00 | 154.0% +25.2 | 0 | 0 | 0 | -0.701 | -0.163 | 0.020 | |
| call 1 Jan | 46.00 | OTM | 0.00 | 2.25 | 0.00 | 0.00 | 140.0% 0.0 | 0 | 0 | 0 | 0.282 | -0.178 | 0.020 |
| put 1 Jan | ITM | 4.00 | 7.50 | 0.00 | 0.00 | 151.5% +11.4 | 0 | 0 | 0 | -0.718 | -0.173 | 0.020 | |
| call 1 Jan | 47.00 | OTM | 0.00 | 2.25 | 0.00 | 0.00 | 150.7% 0.0 | 0 | 0 | 0 | 0.269 | -0.187 | 0.019 |
| put 1 Jan | ITM | 5.00 | 8.70 | 0.00 | 0.00 | 172.3% +21.6 | 0 | 0 | 0 | -0.731 | -0.182 | 0.019 | |
| call 1 Jan | 48.00 | OTM | 0.00 | 2.25 | 0.00 | 0.00 | 160.8% 0.0 | 0 | 0 | 0 | 0.257 | -0.195 | 0.019 |
| put 1 Jan | ITM | 6.00 | 9.50 | 0.00 | 0.00 | 172.9% +12.0 | 0 | 0 | 0 | -0.743 | -0.190 | 0.019 | |
| call 30 Oct | 49.00 | OTM | 0.00 | 1.50 | 0.05 | 0.00 | 170.5% 0.0 | 2 | 0 | 0 | 0.247 | -0.202 | 0.018 |
| put 1 Jan | ITM | 6.90 | 10.60 | 0.00 | 0.00 | 188.0% +17.5 | 0 | 0 | 0 | -0.753 | -0.197 | 0.018 | |
| call 30 Oct | 50.00 | OTM | 0.00 | 0.75 | 0.10 | 0.00 | 78.1% 0.0 | 8 | 0 | 0 | 0.029 | -0.020 | 0.004 |
| put 1 Jan | ITM | 7.90 | 11.80 | 0.00 | 0.00 | 207.9% +129.8 | 0 | 0 | 0 | -0.971 | -0.014 | 0.004 | |
| call 1 Jan | 55.00 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 104.6% 0.0 | 0 | 0 | 0 | 0.023 | -0.021 | 0.003 |
| put 1 Jan | ITM | 12.90 | 16.30 | 0.00 | 0.00 | 223.4% +118.7 | 0 | 0 | 0 | -0.977 | -0.015 | 0.003 | |
| call 1 Jan | 60.00 | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 127.9% 0.0 | 0 | 0 | 0 | 0.019 | -0.023 | 0.003 |
| put 1 Jan | ITM | 17.90 | 21.80 | 0.00 | 0.00 | 288.6% +160.6 | 0 | 0 | 0 | -0.981 | -0.016 | 0.003 |
Latest SEC filings
30 of 1,012AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-09, period ended 2026-09-30. 10-K filed 2026-05-20, period ended 2026-03-31. ROIV on EDGAR
page 1 of 34Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 144 | no category | no report period | 0001950047-26-011011 index |
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001635088-26-000148 index |
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001635088-26-000147 index |
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001635088-26-000146 index |
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001635088-26-000139 index |
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001635088-26-000137 index |
| 2026-11-10 | 144 | no category | no report period | 0001965301-26-000177 index |
| 2026-11-10 | 144/A | no category | no report period | 0001950047-26-010969 index |
| 2026-11-10 | 144/A | no category | no report period | 0001950047-26-010968 index |
| 2026-11-10 | 144/A | no category | no report period | 0001950047-26-010967 index |
| 2026-11-10 | 144 | no category | no report period | 0001950047-26-010956 index |
| 2026-11-10 | 144 | no category | no report period | 0001950047-26-010941 index |
| 2026-11-10 | 144 | no category | no report period | 0001950047-26-010935 index |
| 2026-11-10 | 144 | no category | no report period | 0001950047-26-010932 index |
| 2026-11-09 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001635088-26-000132 index |
| 2026-11-09 | 8-K | All annual, quarterly, and current reports | 2026-11-09 | 0001635088-26-000130 index |
| 2026-11-05 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-03 · transaction | 0001635088-26-000123 index |
| 2026-11-05 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0000315066-26-002842 index |
| 2026-11-03 | 144 | no category | no report period | 0001965301-26-000170 index |
| 2026-10-30 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-28 · transaction | 0001635088-26-000120 index |
| 2026-10-28 | 144 | no category | no report period | 0001965301-26-000167 index |
| 2026-10-27 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002012383-26-003714 index |
| 2026-10-27 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-23 · transaction | 0001807359-26-000020 index |
| 2026-10-27 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-23 · transaction | 0001635088-26-000118 index |
| 2026-10-27 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-23 · transaction | 0001209181-26-000009 index |
| 2026-10-22 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-20 · transaction | 0001635088-26-000116 index |
| 2026-10-21 | 8-K | All annual, quarterly, and current reports | 2026-10-21 | 0001140361-26-040332 index |
| 2026-10-20 | 144 | no category | no report period | 0001965301-26-000163 index |
| 2026-10-20 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-16 · transaction | 0001635088-26-000114 index |
| 2026-10-20 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-16 · transaction | 0001635088-26-000113 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 27.35M | 4 |
| 2026-10 | 0 | 0 | 14.98M | 3 |
| 2026-09 | 0 | 0 | 8.52M | 4 |
| 2026-08 | 0 | 0 | 43.67M | 7 |
| 2026-07 | 0 | 0 | 6.99M | 1 |
| 2026-06 | 0 | 0 | 162.74M | 13 |
| 2026-05 | 0 | 0 | 6.05M | 1 |
| 2026-04 | 0 | 0 | 14.75M | 3 |
| 2026-03 | 0 | 0 | 8.77M | 3 |
| 2026-02 | 0 | 0 | 194.30M | 14 |
| 2026-01 | 0 | 0 | 4.38M | 1 |
| 2025-12 | 0 | 0 | 271.86M | 17 |
| 2025-11 | 0 | 0 | 120.90M | 7 |
Institutional holders
| Manager | % owned |
|---|---|
| FMR LLC | 11.85% |
| BlackRock, Inc. | 6.71% |
| MORGAN STANLEY | 5.92% |
| QVT Financial LP | 3.30% |
| STATE STREET CORP | 3.10% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.08% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.01% |
| GOLDMAN SACHS GROUP INC | 2.58% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.99% |
| UBS Group AG | 1.93% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Growth Company Fund | 3.19% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.22% |
| iShares Core S&P Mid-Cap ETF | 2.15% |
| VANGUARD SMALL-CAP INDEX FUND | 1.61% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 0.93% |
| Fidelity Growth Company K6 Fund | 0.92% |
| Fidelity Series Growth Company Fund | 0.78% |
| GROWTH PORTFOLIO | 0.73% |
| Invesco S&P MidCap Momentum ETF | 0.72% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.72% |
OakChart. ROIV. Cached 15 minutes. Terms